Assessment of Patients Treated with Kampo Decoctions Containing Aconite Root Before Processing (uzu)
- VernacularTitle:福島県立医科大学会津医療センターにおける烏頭含有方剤使用例の解析
- Author:
Toshihito TSUBO
1
;
Takaharu UENO
2
;
Tomoko SUZUKI
3
;
Syuichiro AKIBA
3
;
Yoshiro SAHASHI
4
;
Hiromi KOMIYA
5
;
Tadamichi MITSUMA
3
Author Information
- Keywords: uzu; aconite root
- From:Kampo Medicine 2019;70(4):324-332
- CountryJapan
- Language:Japanese
- Abstract: We examined 57 patients treated with Kampo decoctions containing uzu for 5 years and 3 months from September 2013. Sekiganryo, which was administered to 32 patients, was the most commonly used decoction. The value of uzu dosage and duration of administration were spread widely and the medians (ranges) are 8.0 (1.0-41.0)g/day and 180 (3-1700) days, respectively. Complete recovery, partial recovery, no recovery, and deterioration in terms of the chief complaint, were observed in 36, 11, 9, and 1 patients, respectively. The number of patients exhibiting complete or partial recovery was higher than that of patients showing no recovery or deterioration when the duration of uzu administration was more than one month and the dosage was higher than 4 g/day (p < 0.05). The patients treated with uzu more than 20 g/day were all sekiganryo administrated ones. Side effects were observed in three patients. Thus, under careful observation, uzu was safely used over a long term and at high doses.uzu: aconite root before processing
